Gossamer Bio Inc (GOSS)
0.74
-0.03
(-4.06%)
USD |
NASDAQ |
May 03, 16:00
0.7351
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Total Liabilities (Quarterly): 249.15M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 249.15M |
| September 30, 2023 | 243.31M |
| June 30, 2023 | 244.55M |
| March 31, 2023 | 248.36M |
| December 31, 2022 | 260.37M |
| September 30, 2022 | 267.19M |
| June 30, 2022 | 262.30M |
| March 31, 2022 | 264.52M |
| December 31, 2021 | 222.19M |
| September 30, 2021 | 217.23M |
| June 30, 2021 | 211.82M |
| March 31, 2021 | 210.38M |
| Date | Value |
|---|---|
| December 31, 2020 | 218.75M |
| September 30, 2020 | 212.08M |
| June 30, 2020 | 204.75M |
| March 31, 2020 | 65.02M |
| December 31, 2019 | 74.12M |
| September 30, 2019 | 70.88M |
| June 30, 2019 | 65.73M |
| March 31, 2019 | 35.69M |
| December 31, 2018 | 359.49M |
| September 30, 2018 | 15.59M |
| December 31, 2017 | 7.307M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
65.02M
Minimum
Mar 2020
267.19M
Maximum
Sep 2022
200.67M
Average
218.75M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 617.71M |
| TG Therapeutics Inc | 213.21M |
| Replimune Group Inc | 111.39M |
| 89bio Inc | 59.96M |
| Moderna Inc | 3.912B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 311.92M |
| Shareholders Equity (Quarterly) | 62.77M |